-
Alteplase, sold
under the
brand name
Activase among others, is a
biosynthetic form of
human tissue-type
plasminogen activator (t-PA). It is a thrombolytic...
-
producing types of
recombinant tissue plasminogen activator (rtPA) such as
alteplase, reteplase, and tenecteplase.
These drugs are used in
clinical medicine...
- medications, such as
anticoagulants and
thrombolytic tpA
medication (such as
alteplase)
which can
increase the
bleeding risk.
Effective treatment is complex...
- high and therefore,
treatment using streptokinase is not recommended.
Alteplase is a
recombinant tissue plasminogen activator which enhances the conversion...
-
Management of
Acute Ischemic Stroke supports considering tenecteplase over
alteplase in
patients without contraindication to
intravenous thrombolytics. "Tnkase-...
-
medical imaging between 4.5
hours and 9
hours or who wake up with stroke,
alteplase results in some benefit. Its use is
endorsed by the
American Heart ****ociation...
- (
alteplase), but the
modifications give
reteplase a
longer half-life of 13–16 minutes.
Reteplase also
binds fibrin with
lower affinity than
alteplase,...
-
manufactured using recombinant techniques and is sold as
alteplase, reteplase, and tenecteplase.
Alteplase was the
first of
these versions to go on the market...
-
Vidara Therapeutics and
finally Horizon Pharma as of 2019.
Activase (
alteplase), for
heart attacks.
Akynzeo (netupitant/palonosetron), for
nausea and...
- with
thrombolysis (clot dissolution) by
thrombolytic medications (e.g.,
alteplase, reteplase), as
either alternative or
complement thereto. It is commonly...
